You are here

  • Home
  • Archive
  • Volume 64, Issue Suppl 1
  • PTH-188 Is it more cost-effective to treat patients with non-dysplastic barrett’s oesophagus with aspirin and statins rather than to undertake endoscopic surveillance?

Article info

Article menu
Download PDFPDF
Oesophagus, Stomach, Duodenum III
PTH-188 Is it more cost-effective to treat patients with non-dysplastic barrett’s oesophagus with aspirin and statins rather than to undertake endoscopic surveillance?

Authors

Citation

Menon S, Trudgill N
PTH-188 Is it more cost-effective to treat patients with non-dysplastic barrett’s oesophagus with aspirin and statins rather than to undertake endoscopic surveillance?
Gut 2015;64:A491-A492.

Publication history

  • First published June 22, 2015.
Online issue publication 
April 18, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions